Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
Janux Therapeutics’ $350 Million Common Stock Offering
Extra Space Storage’s $400 Million Notes Offering
Latham & Watkins advised Extra Space Storage on the offering. Extra Space Storage Inc. (NYSE: EXR), a leading owner and operator of self-storage facilities in the...
Boundless Bio’s $100 Million IPO
Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Boundless Bio on the offering, and Cooley advised the underwriters. Boundless Bio, Inc. (Nasdaq: BOLD) a clinical...
Iovance Biotherapeutics’ US$211 Million Common Stock Offering
DLA Piper advised Iovance Biotherapeutics, Latham & Watkins advised the underwriters on the transaction. Iovance Biotherapeutics, Inc. (Iovance), a biotechnology company focused on innovating, developing and...
Topgolf Callaway’s $29 Million Acquisition of Bigshots Golf
Latham & Watkins advised Topgolf Callaway on the transaction, and Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo advised Invited, Inc. Topgolf Callaway Brands Corp. (NYSE: MODG)...
Crinetics Pharmaceuticals’ $350 Million Public Offering of Common Stock
Latham & Watkins advised Crinetics, and Cooley advised the underwriters on the offering. Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) announced the pricing of an upsized underwritten public...
Tapestry, Inc.’s US$8.5 Billion Acquisition Of Capri Holdings
Latham & Watkins advises Tapestry, Inc. in the acquisition of Capri Holdings advised by Wachtell, Lipton, Rosen & Katz. Tapestry, Inc. (NYSE: TPR), a house of...
Mineralys Therapeutics’ $192 Million Initial Public Offering
Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters. Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public...